Compound class

Testosterone esters

Testosterone with an acid group attached, which changes how long it lasts.

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.

Esterification of the 17-beta-hydroxy group increases the duration of action of testosterone, according to the US label for testosterone enanthate.1 Most esters come as oil injections: the label calls testosterone cypionate an oil-soluble ester.2

The Depo-Testosterone label gives a half-life of approximately eight days for testosterone cypionate injected intramuscularly.2 In a separate single-dose study of 1,000 mg intramuscular testosterone undecanoate in 14 hypogonadal men, FDA's review reports a mean half-life of 53.46 days for serum total testosterone.3 Undecanoate also comes as a capsule.4

Compounds in this class 9

Guides 9

Calculators 4

Compare 2

Logged in Milligram

Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.

  • Testosterone Enanthate22%
  • Testosterone Cypionate13%

Testosterone Enanthate, how often

  • Daily17%
  • Every other day35%
  • Twice a week38%
  • Weekly7%
  • Less often3%

Testosterone Cypionate, how often

  • Daily20%
  • Every other day32%
  • Twice a week35%
  • Weekly12%
  • Less often2%

How often: among people with three or more logged doses, by the average gap between their doses.

Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.

References 9

  1. Hikma Pharmaceuticals USA Inc. Testosterone Enanthate Injection, USP (Hikma Pharmaceuticals USA Inc.). 2026. DailyMed label
  2. Pharmacia & Upjohn Company LLC (Pfizer). Depo-Testosterone (testosterone cypionate) injection, USP CIII (Pharmacia & Upjohn Company LLC). 2025. DailyMed label
  3. US Food and Drug Administration. Clinical pharmacology and biopharmaceutics review(s), NDA 022219 (Aveed). 2014. accessdata.fda.gov
  4. Tolmar Inc. JATENZO (testosterone undecanoate) capsule, liquid filled (Tolmar Inc.). 2026. DailyMed label
  5. Rivero MJ, et al. Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial. J Urol 2023. PMID 37126399
  6. Anderson FH, et al. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res 1997. PMID 9076591
  7. Aspen Pharma Trading Limited. Sustanon 250, 250mg/ml solution for injection. Summary of Product Characteristics, electronic Medicines Compendium (UK), text revised December 2025. emc SmPC
  8. Aspen Pharma Trading Limited. Sustanon 250, 250mg/ml solution for injection: Summary of Product Characteristics (electronic medicines compendium, UK). Updated 16 February 2026. emc SmPC
  9. Endo USA, Inc. Aveed (testosterone undecanoate) injection, for intramuscular use, CIII. DailyMed label, revised July 2025. DailyMed label

Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.